Publications
460 publications
- Date
- Relevance
-
GVS advice tezepelumab (Tezspire®) for the treatment of patients 12 years and older with severe asthma
The National Health Care Institute has assessed whether tezepelumab (Tezspire®) can be included in the Medicine Reimbursement ...
-
Package advice for the lock procedure medicinal product ravulizumab (Ultomiris®) for the treatment of adult patients with myasthenia gravis
The National Health Care Institute has assessed whether the medicinal product ravulizumab (Ultomiris®) can be reimbursed from the ...
-
GVS advice empagliflozin (Jardiance®) expansion List 2 conditions for chronic kidney disease
The National Health Care Institute has assessed whether the reimbursement conditions for empagliflozin (Jardiance®) can be ...
-
Monitoring the vitamin D package measure
The Minister of Health, Welfare and Sport (VWS) decided to discontinue the reimbursement of all vitamin D products containing ...
-
Update advice on the lock procedure for the medicinal product atidarsagene autotemcel (Libmeldy®) for the treatment of metachromatic leukodystrophy (MLD)
The National Health Care Institute advises the Minister of Health, Welfare and Sport (VWS) to renegotiate the price of ...
-
Final report – Case study phase ROR DGM
The Dutch National Health Care Institute presents its vision on data availability in healthcare, based on 4 completed case ...
-
GVS advice on latanoprost/netarsudil (Roclanda®) for the treatment of glaucoma and ocular hypertension
The National Health Care Institute has assessed whether latanoprost in combination with netarsudil (Roclanda®) can be included in ...
-
Package advice lock procedure product emicizumab (Hemlibra®) for the treatment of moderate haemophilia A
The National Health Care Institute has assessed whether emicizumab (Hemlibra®) can be reimbursed from the basic health care ...
-
Orphan drug arrangement givosiran (Givlaari®) for the treatment of acute hepatic porphyria
Agreements have been made to promote appropriate use of givosiran (Givlaari®) as treatment of acute hepatic porphyria, a rare ...
-
Organisation chart 2023
Organisation chart 2023